Pfizer PFE reported its Q3 earnings results on Tuesday, November 1, 2022 at 06:45 AM.
Here's what investors need to know about the announcement.
Earnings
Pfizer beat estimated earnings by 21.09%, reporting an EPS of $1.78 versus an estimate of $1.47.
Revenue was down $1.46 billion from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.24 which was followed by a 0.41% drop in the share price the next day.
Here's a look at Pfizer's past performance:
Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
---|---|---|---|---|
EPS Estimate | 1.80 | 1.50 | 0.87 | 1.09 |
EPS Actual | 2.04 | 1.62 | 1.08 | 1.34 |
Revenue Estimate | 25.98B | 23.95B | 24.20B | 22.71B |
Revenue Actual | 27.74B | 25.66B | 23.84B | 24.09B |
To track all earnings releases for Pfizer visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.